Trodelvy® Significantly Improves Overall Survival in Pre-Treated[...]
Navidea Biopharmaceuticals Inc.
Navidea Biopharmaceuticals Reports Second Quarter 2022 Financial Results
06/22/2022 | Press release | Distributed by Public on 06/22/2022 10:22
Please select the service you want to use:
Smartlinks | Seadrill Ltd. | News | Health | Finance | Energy Markets | Commodities | Company News | Business Announcement | Contracts and Orders | Energy Markets | Oil and Gas | Oil and Gas Upstream Activities | Cruises | Travel, Leisure and Recreation Industry | Cruises | Public Companies | Oil and Gas Equipment and Services Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Euronext Oslo | Tradegate Exchange | Nasdaq Stockholm | Börse Hamburg | Börse Hannover | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact